Delivery Order SPE2DB22D2009-SPE2DB25FM0BD
Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,290.83 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets (30-count packaging) under a firm fixed price contract. This non-set-aside delivery order, awarded on June 2, 2025, with completion scheduled for June 3, 2025, will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $19,710.72 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets in a 30-count package. The contract was competitively awarded without set-aside designation on May 27, 2025, with a completion date of May 28, 2025. This delivery order operates under a firm fixed-price arrangement and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for REXULTI 3 mg tablets (30-count packaging) with a ceiling value of $2,928.63 under a firm fixed price contract type. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and was executed without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,259.26 for REXULTI 0.5 mg tablets (30-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) leverages AmerisourceBergen's position as a prime vendor under the DLA Troop Support Medical Indefinite Delivery Contract SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,620.81 to AmerisourceBergen Drug Corp for the supply of REXULTI 2 mg tablets (30-count packaging) with a firm fixed price and an ultimate completion date of September 11, 2025. This non-set-aside competitive award was issued on September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $23,464.63 to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count supply) with an ultimate completion date of July 1, 2025. This firm fixed-price, non-set-aside contract represents a single delivery under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,495.49 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 1 mg REXULTI tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies in support of military healthcare programs. The contract does not have a set-aside designation and is expected to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for REXULTI 3 MG tablets (30-count supply) with a ceiling value of $22,083.84. This firm fixed price delivery order represents a non-competitive set-aside contract and is scheduled for ultimate completion by August 8, 2025. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REXULTI 2 mg tablets. The $3,234.78 contract has an ultimate completion date of April 1, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product REXULTI 1 MG TABLET 30S. The contract, valued at $1,436.77, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award. This delivery order...